2004-2018 年挪威青光眼的患病率和发病率：一项全国基于人群的研究。
The prevalence and incidence of glaucoma in Norway 2004-2018: A nationwide population-based study.
机构信息
Department of Ophthalmology, Oslo University Hospital, Oslo, Norway.
Institute of Clinical Medicine, University of Oslo, Oslo, Norway.
出版信息
PLoS One. 2020 Dec 10;15(12):e0242786. doi: 10.1371/journal.pone.0242786. eCollection 2020.
PURPOSE
To describe prevalence, life-time prevalence and incidence of glaucoma in Norway over a 15-year period.
MATERIALS AND METHODS
Data from The Norwegian Prescription Database was used to identify all prescriptions for glaucoma medication during the period 2004 to 2018. Population figures and lifespan data were obtained from The National Bureau of Statistics.
RESULTS
Of a population of 5.3 million, a total of 75733 patients using glaucoma eye drops were identified in 2018. The national prevalence was thus 1.4%, whilst in those over 70 years of age, 8.0%. When divided into counties, the prevalence varied between 1.1 and 1.9%. Overall, the prevalence was stable in the period 2004-2018. Life time prevalence was found to be 9.4% for men and 10.2% for women. National one-year incidence proportion per 10000 was 17.0 for the total population and a peak incidence of 93.8/10000 in the 80-89 year age group was identified.
CONCLUSIONS
Glaucoma prevalence remained stable during the period 2004-2018, while incidence decreased slightly in the elderly population.
目的
描述挪威在 15 年内青光眼的患病率、终身患病率和发病率。
材料和方法
使用挪威处方数据库的数据来确定 2004 年至 2018 年期间所有青光眼药物处方。人口数据和寿命数据来自国家统计局。
结果
在 530 万人口中，2018 年共有 75733 名使用青光眼滴眼液的患者。全国患病率为 1.4%，而 70 岁以上人群的患病率为 8.0%。按县划分，患病率在 1.1%至 1.9%之间。总体而言，2004-2018 年期间患病率保持稳定。发现男性终生患病率为 9.4%，女性为 10.2%。全国每 10000 人一年的发病率比例为 17.0，80-89 岁年龄组的发病率峰值为 93.8/10000。
结论
2004-2018 年期间，青光眼患病率保持稳定，而老年人群的发病率略有下降。
Zotero 插件